Is This Robotics Firm a Giant In The Making?
Inside operating rooms across the globe, a revolution has been underway, one led by Intuitive Surgical (NASDAQ: ISRG).
Over the past five years, the company has more than doubled its profits, yet many argue that it’s still in the early innings of growth.
Key Points
-
Intuitive Surgical has more than doubled profits in five years.
» Read more about: Is This Robotics Firm a Giant In The Making? »
Read More
How High Can NVIDIA Go In 5 Years?
NVIDIA (NASDAQ:NVDA) has been by far one of the best stocks to hold over the last several years. Surging demand for AI data center chips has caused sales of the company’s GPUs to skyrocket, leading to explosive growth and massive returns for investors.
The question now, though, is whether the future will be as good to NVIDIA as the past few years have been.
» Read more about: How High Can NVIDIA Go In 5 Years? »
Read More
Is Roper Technologies a Hidden Gem or an Overpriced Stock?
At a time when tech stocks are surging, it’s somewhat rare to find a technology company that hasn’t advanced by double or even triple digits in the last 12 months. Today, however, we’ll be looking at one that has remained largely flat even as investors poured into practically every tech company they could find.
Roper Technologies (NYSE:ROP) has advanced less than 6 percent in the last 12 months despite solid revenue and earnings growth.
» Read more about: Is Roper Technologies a Hidden Gem or an Overpriced Stock? »
Read MoreDoorDash’s Soaring Stock: A Smart Buy or a Bubble Waiting to Burst?
Gig economy food delivery service DoorDash (NASDAQ:DASH) has been running hot for most of the last year, gaining over 75 percent in the last 12 months. Such large increases, though, often leave stocks susceptible to corrections that bring their prices back down to earth. We examine DoorDash’s performance and valuation to see whether the stock is a buy,
» Read more about: DoorDash’s Soaring Stock: A Smart Buy or a Bubble Waiting to Burst? »
Read More
Is This Healthcare Stock Set To Rally?
Eli Lilly has been a frustrating hold so far this year. Shares are slightly down year to date, a rare stumble for a company that has delivered nearly 5x returns over the past five years.
For a stock that’s become a poster child of the weight-loss and diabetes boom, the slowdown in momentum has left investors wondering if the story has run its course.
» Read more about: Is This Healthcare Stock Set To Rally? »
Read MoreThe Burst
Is SoFi Still a Once-in-a-Generation Fintech Opportunity
SoFi’s rise over the past few years has been stunning. SoFi’s stock has surged over 3x over the past 3 years, handily outpacing blue-chip tech names, even those riding the artificial intelligence wave. But that eye-popping run might be both a blessing and a curse.
Investors are now wondering whether SoFi keep up the pace?
» Read more about: Is SoFi Still a Once-in-a-Generation Fintech Opportunity »
Read MoreThe Spotlight
Has The Golden Age For Twilio Started?
Twilio is one of those companies that not many individuals know much about but which is used widely by over 300,000 businesses.
It essentially powers SMS communications so let’s say you’re a Dell or Shopify or Toyota and want to message your own audiences, you would sign up to Twilio to engage with them.
» Read more about: Has The Golden Age For Twilio Started? »
Read MoreThe Daily
Goldman Sachs Targets 12% Gain for S&P 500: Here’s Why
Many investors get exposure to the S&P 500 through exchange traded funds (ETFs) like the SPDR S&P 500 ETF (NYSEARCA:SPY) or the Vanguard S&P 500 ETF (NYSEARCA:VOO). A prominent group of analysts expect these S&P 500 funds to perform well in 2026 — but then,
» Read more about: Goldman Sachs Targets 12% Gain for S&P 500: Here’s Why »